290 related articles for article (PubMed ID: 25350583)
21. Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress.
Hawe A; Kasper JC; Friess W; Jiskoot W
Eur J Pharm Sci; 2009 Sep; 38(2):79-87. PubMed ID: 19540340
[TBL] [Abstract][Full Text] [Related]
22. Assessing the Utility of Circular Dichroism and FTIR Spectroscopy in Monoclonal-Antibody Comparability Studies.
Lin JC; Glover ZK; Sreedhara A
J Pharm Sci; 2015 Dec; 104(12):4459-4466. PubMed ID: 26505267
[TBL] [Abstract][Full Text] [Related]
23. Integrated system for temperature-controlled fast protein liquid chromatography. III. Continuous downstream processing of monoclonal antibodies.
Ketterer B; Moore-Kelly C; Thomas ORT; Franzreb M
J Chromatogr A; 2020 Jan; 1609():460429. PubMed ID: 31431354
[TBL] [Abstract][Full Text] [Related]
24. Conformational stability, reversibility and heat-induced aggregation of α-1-acid glycoprotein.
Iwura T; Fukuda J; Yamazaki K; Arisaka F
J Biochem; 2014 Dec; 156(6):345-52. PubMed ID: 25147193
[TBL] [Abstract][Full Text] [Related]
25. Biophysical study of bevacizumab structure and bioactivity under thermal and pH-stresses.
Sousa F; Sarmento B; Neves-Petersen MT
Eur J Pharm Sci; 2017 Jul; 105():127-136. PubMed ID: 28502677
[TBL] [Abstract][Full Text] [Related]
26. Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody.
Menzen T; Friess W
J Pharm Sci; 2014 Feb; 103(2):445-55. PubMed ID: 24382634
[TBL] [Abstract][Full Text] [Related]
27. High throughput thermostability screening of monoclonal antibody formulations.
He F; Hogan S; Latypov RF; Narhi LO; Razinkov VI
J Pharm Sci; 2010 Apr; 99(4):1707-20. PubMed ID: 19780136
[TBL] [Abstract][Full Text] [Related]
28. Pulse Proteolysis: An Orthogonal Tool for Protein Formulation Screening.
Iyer LK; Phanse R; Xu M; Lan W; Krause ME; Bolgar M; Hart S
J Pharm Sci; 2019 Feb; 108(2):842-850. PubMed ID: 30257193
[TBL] [Abstract][Full Text] [Related]
29. A thermal-cycling method for disaggregating monoclonal antibody oligomers.
Sadavarte RH; Ghosh R
J Pharm Sci; 2014 Mar; 103(3):870-8. PubMed ID: 24549731
[TBL] [Abstract][Full Text] [Related]
30. The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity.
Knight MJ; Floret L; Patel N; O'Hara J; Rodriguez E
MAbs; 2022; 14(1):2127172. PubMed ID: 36198003
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions.
Nicoud L; Jagielski J; Pfister D; Lazzari S; Massant J; Lattuada M; Morbidelli M
J Phys Chem B; 2016 Apr; 120(13):3267-80. PubMed ID: 27007829
[TBL] [Abstract][Full Text] [Related]
32. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
Zidar M; Šušterič A; Ravnik M; Kuzman D
Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
[TBL] [Abstract][Full Text] [Related]
33. Laser-induced breakdown detection of temperature-ramp generated aggregates of therapeutic monoclonal antibody.
Menzen T; Friess W; Niessner R; Haisch C
Eur J Pharm Biopharm; 2015 Aug; 94():463-7. PubMed ID: 26158409
[TBL] [Abstract][Full Text] [Related]
34. A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding.
Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
Biotechnol J; 2012 Jan; 7(1):127-32. PubMed ID: 21953825
[TBL] [Abstract][Full Text] [Related]
35. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
Brummitt RK; Nesta DP; Roberts CJ
J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
[TBL] [Abstract][Full Text] [Related]
36. DSF method optimization and its application in predicting protein thermal aggregation kinetics.
Shi S; Semple A; Cheung J; Shameem M
J Pharm Sci; 2013 Aug; 102(8):2471-83. PubMed ID: 23754479
[TBL] [Abstract][Full Text] [Related]
37. Application of circular dichroism and magnetic circular dichroism for assessing biopharmaceuticals formulations photo-stability and small ligands binding properties.
Longo E; Hussain R; Siligardi G
Int J Pharm; 2015 Mar; 480(1-2):84-91. PubMed ID: 25596417
[TBL] [Abstract][Full Text] [Related]
38. Aggregation stability of a monoclonal antibody during downstream processing.
Arosio P; Barolo G; Müller-Späth T; Wu H; Morbidelli M
Pharm Res; 2011 Aug; 28(8):1884-94. PubMed ID: 21448757
[TBL] [Abstract][Full Text] [Related]
39. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
Barnard JG; Singh S; Randolph TW; Carpenter JF
J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
[TBL] [Abstract][Full Text] [Related]
40. Effects of thermal and mechanical stress on the physical stability of human growth hormone and epidermal growth factor.
Lim JY; Kim NA; Lim DG; Kim KH; Jeong SH
Arch Pharm Res; 2015 Aug; 38(8):1488-98. PubMed ID: 25430693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
